Used in pharmaceutical research as a potent and selective antagonist for the melanin-concentrating hormone receptor 1 (MCHr1), this compound is investigated for its potential in treating obesity and metabolic disorders. It modulates appetite regulation and energy balance in preclinical models, making it a candidate for anti-obesity drug development. Additionally, it has been explored for possible anxiolytic and antidepressant effects due to MCHr1’s role in mood regulation. Its application remains primarily in early-stage drug discovery and biological studies.